首页> 外国专利> Medicinal product containing tiotropium, for treatment of asthma or chronic obstructive pulmonary disease, comprising powdered drug and carrier in container with high protection dry seal, for use in powder inhaler

Medicinal product containing tiotropium, for treatment of asthma or chronic obstructive pulmonary disease, comprising powdered drug and carrier in container with high protection dry seal, for use in powder inhaler

机译:含有噻托铵的药物,用于治疗哮喘或慢性阻塞性肺疾病,包括粉状药物和带有高保护性干封的容器中的载体,用于粉末吸入器

摘要

A novel medicinal product (A) consists of a dose of powdered medicament in a container for use in a dry powder inhaler, where the medicament comprises fine particles of tiotropium (I) and dry carrier(s) (II), the container has a high protection dry seal and the powder doses are provided by volumetric or electrical field dosing. Independent claims are included for: (1) apparatus comprising a dry powder inhaler and (A), specifically where (a) (A) is contained in the inhaler or (b) the inhaler and (A) are separate, and the container of (A) comprises a first part to be inserted into the inhaler and a second part enclosing the first part in moisture-impermeable packaging; and (2) a kit comprising a dry powder inhaler and (A), (A) being separate from, but suitable for insertion into, the inhaler. ACTIVITY : Antiasthmatic; antiinflammatory. MECHANISM OF ACTION : Anticholinergic.
机译:一种新型药物产品(A)由装在干粉吸入器中的容器中的一定剂量的粉状药物组成,其中该药物包含噻托铵(I)和干载体(II)的细颗粒,该容器具有一个高保护性干密封,粉末剂量由体积或电场剂量提供。包括以下方面的独立权利要求:(1)包括干粉吸入器和(A)的设备,特别是其中(a)吸入器中包含(A)或(b)吸入器和(A)分开的容器,以及(A)包括要插入吸入器的第一部分和将第一部分封闭在不透湿包装中的第二部分; (2)包括干粉吸入器的套件,以及(A),(A)与吸入器分离但适合插入吸入器。活动:平喘;消炎(药。作用机理:抗胆碱能。

著录项

  • 公开/公告号DE202005002409U1

    专利类型

  • 公开/公告日2005-07-07

    原文格式PDF

  • 申请/专利权人 MICRODRUG AG HERGISWIL;

    申请/专利号DE20052002409U

  • 发明设计人

    申请日2005-02-15

  • 分类号A61M15/00;A61J1/00;A61J3/00;

  • 国家 DE

  • 入库时间 2022-08-21 22:00:18

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号